Cargando…
Aptamer BC 007 - Efficient binder of spreading-crucial SARS-CoV-2 proteins
Corona virus disease 2019 (COVID-19) is a respiratory disease caused by a new coronavirus (SARS-CoV-2) which causes significant morbidity and mortality. The emergence of this novel and highly pathogenic SARS-CoV-2 and its rapid international spread poses a serious global public health emergency. To...
Autores principales: | Weisshoff, Hardy, Krylova, Oxana, Nikolenko, Heike, Düngen, Hans-Dirk, Dallmann, Andre, Becker, Susanne, Göttel, Peter, Müller, Johannes, Haberland, Annekathrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605794/ https://www.ncbi.nlm.nih.gov/pubmed/33163683 http://dx.doi.org/10.1016/j.heliyon.2020.e05421 |
Ejemplares similares
-
Aptamer BC 007’s Affinity to Specific and Less-Specific Anti-SARS-CoV-2 Neutralizing Antibodies
por: Haberland, Annekathrin, et al.
Publicado: (2021) -
In-Vivo Degradation of DNA-Based Therapeutic BC 007 in Humans
por: Davideit, Hanna, et al.
Publicado: (2019) -
The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman Pinschers of efficacy and outcomes
por: Werner, Sabine, et al.
Publicado: (2020) -
A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects
por: Becker, Niels-Peter, et al.
Publicado: (2020) -
Aptamers Against COVID-19: An Untested Opportunity
por: Haberland, Annekathrin, et al.
Publicado: (2022)